Antigenic anarogues of platelet activating factor
US5061626A · kind A · utility
31Cited by
5References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 24, 1987 |
| Grant date | Oct 29, 1991 |
| Priority date | — |
| Expiry date | Nov 24, 2007 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K39/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention concerns antigens for the production of antibodies to Platelet Activating Factor (PAF). The antigens are PAF analogues of formula (I) ##STR1## wherein X comprises a high molecular weight group, R.sup.1 is a linking group and R.sup.2 to R.sup.5 are selected from C.sub.1 to C.sub.6 alkyl. Other aspects of the invention include PAF-antibodies produced using said antigens, labelled PAF analogues, intermediates for the preparation of PAF analogues and methods and a kit for the immunoassay of PAF.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.